← Open Payments lookup

LINDSAY PONSTEIN: Open Payments

NPI 1598005522 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,575 in 124 payments from 23 companies in 2025. Trend: 2023 $2,560 · 2024 $2,860 · 2025 $2,575

Food & beverage: $2,575
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP17$345
GlaxoSmithKline, LLC.21$321
GENZYME CORPORATION11$309
Regeneron Healthcare Solutions, Inc.7$269
Merck Sharp & Dohme LLC10$202
Verona Pharma, Inc.9$178
Boehringer Ingelheim Pharmaceuticals, Inc.3$169
Insmed, Inc.6$135
Astellas Pharma US Inc3$95
ABBVIE INC.5$87

Products named: DUPIXENT, Ohtuvayre, TRELEGY ELLIPTA, NUCALA, BREZTRI, Arikayce, PIFELTRO, FASENRA.

Industry payments across LA — which companies pay providers there.